OPKO Health, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
OPK Nasdaq 2830 www.opko.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for OPKO Health, Inc.

Discover 3 Promising Penny Stocks With Market Caps Over $20M - Jun 9th, 2026 6:05 am
Assessing OPKO Health (OPK) Valuation After Expanded Nicoya RAYALDEE Partnership In Greater China - Jun 7th, 2026 3:19 pm
How Investors May Respond To OPKO Health (OPK) Boosting Its Nicoya Stake And RAYALDEE Milestones - Jun 6th, 2026 9:09 pm
OPKO Health (OPK) Amends Partnership With Nicoya Therapeutics to Gain Equity Stake - Jun 5th, 2026 3:57 pm
OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue? - May 28th, 2026 9:30 am
Here's Why You Should Retain OPK Stock in Your Portfolio for Now - May 21st, 2026 10:23 am
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies - May 12th, 2026 6:00 am
Spotlight On Promising Penny Stocks For May 2026 - May 11th, 2026 12:05 pm
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China - Apr 30th, 2026 6:30 am
BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform - Apr 30th, 2026 6:00 am
OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y - Apr 29th, 2026 10:58 am
OPKO Health Inc (OPK) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing ... - Apr 29th, 2026 1:09 am
OPKO Health Q1 Earnings Call Highlights - Apr 28th, 2026 5:39 pm
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates - Apr 28th, 2026 5:00 pm
OPKO Health (OPK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Apr 28th, 2026 5:00 pm
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results - Apr 28th, 2026 2:05 pm
How The OPKO Health (OPK) Narrative Is Shifting After Mixed Results And A Lower Price Target - Apr 23rd, 2026 12:04 pm
Here's Why You Should Hold OPK Stock in Your Portfolio for Now - Apr 23rd, 2026 10:07 am
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas - Apr 22nd, 2026 6:00 am
OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026 - Apr 21st, 2026 2:05 pm